$BIOA
BioAge Labs, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$6.21
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBioAge Labs, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BIOA up today? It is at $6.21 (+0.00%), and our scanner flagged it 67 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BIOA spikes, and full due diligence on BIOA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BIOA 67 times in the last 30 days. Create a free account to track $BIOA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BIOA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIOA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Barton Shane Officer | Sold (automatic/other) | -20K 0.04% of company | n/a | n/a | $509K at $25.19 | Jun 30, 26 |
Barton Shane Officer | Other | 20K 0.04% of company | n/a | 20K | $87K at $4.30 | Jun 30, 26 |
Barton Shane Officer | Sold (automatic/other) | -42K 0.09% of company | n/a | n/a | $1.1M at $25.21 | Jun 29, 26 |
Barton Shane Officer | Other | 40K 0.09% of company | added 100% | 42K | $171K at $4.30 | Jun 29, 26 |
Goldstein Dov A Md Officer | Other | 4K | added 11% | 37K | $16K at $4.38 | Apr 23, 26 |
Rubin Paul D Officer | Sold (automatic/other) | -9K 0.02% of company | n/a | n/a | $157K at $17.81 | Apr 1, 26 |
Rubin Paul D Officer | Other | 9K 0.02% of company | n/a | 9K | $36K at $4.11 | Apr 1, 26 |
Rubin Paul D Officer | Sold (automatic/other) | -7K 0.02% of company | n/a | n/a | $151K at $20.30 | Mar 2, 26 |
Rubin Paul D Officer | Other | 7K 0.02% of company | n/a | 7K | $31K at $4.11 | Mar 2, 26 |
Goldstein Dov A Md Officer | Other | 4K | added 12% | 33K | $16K at $4.38 | Mar 1, 26 |
Rubin Paul D Officer | Sold (automatic/other) | -7K 0.02% of company | n/a | n/a | $139K at $18.75 | Feb 2, 26 |
Rubin Paul D Officer | Other | 7K 0.02% of company | n/a | 7K | $31K at $4.11 | Feb 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BIOA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BIOA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BIOA last traded at $6.21, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
BioAge Labs, Inc. Common Stock (BIOA) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BIOA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BIOA 67 times in the last 30 days.
BIOA (BioAge Labs, Inc. Common Stock) trades on XNAS, with a market cap of about $285M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BIOA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BIOA discussion
Sign in to ask a question or join the discussion.